These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Treatment of circulatory encephalopathy with Cavinton]. Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359 [No Abstract] [Full Text] [Related]
5. Management of hypertensive crises. Feldstein C Am J Ther; 2007; 14(2):135-9. PubMed ID: 17414580 [TBL] [Abstract][Full Text] [Related]
6. [Hypertensive encephalopathy: problem of the therapist (cardiologist) or neurologist?]. Oshchepkova EV Ter Arkh; 2009; 81(1):79-84. PubMed ID: 19253719 [No Abstract] [Full Text] [Related]
7. [The use of cavinton in patients with lacunar stroke developed against the background of diabetes mellitus and arterial hypertension]. Spirin NN; Pizova NV; Shadrichev VA; Filatov VF; Bakucheva MV Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):64-6. PubMed ID: 18688926 [No Abstract] [Full Text] [Related]
8. [Chronic disorders of cerebral blood circulation: possibilities of the use of cavinton]. Kamchatnov PR; Zaĭtsev KA; Chugunov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):52-6. PubMed ID: 20740716 [No Abstract] [Full Text] [Related]
9. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"]. Chukanova EI Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):49-52. PubMed ID: 21311488 [TBL] [Abstract][Full Text] [Related]
10. [The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL]. Tabeeva GR; Azimova IuE Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12 Pt 2):20-30. PubMed ID: 23388602 [TBL] [Abstract][Full Text] [Related]
11. [The results of clinical study of cavinton efficacy inpatients with chronic brain ischemia]. Doronin BM; Popova TF; Kornach NV; Klimova LA; Volkova II; Chelysheva LV Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):48-50. PubMed ID: 19253466 [No Abstract] [Full Text] [Related]
13. Fatal hypertensive crisis as presentation of mitochondrial complex I deficiency. Lohmeier K; Distelmaier F; van den Heuvel LP; Rodenburg RJ; Smeitink J; Mayatepek E; Hoehn T Neuropediatrics; 2007 Jun; 38(3):148-50. PubMed ID: 17985265 [TBL] [Abstract][Full Text] [Related]
14. [The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy]. Odinak MM; Lobzin VIu Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):63-4. PubMed ID: 20213894 [No Abstract] [Full Text] [Related]
15. [Experience with the use of cavinton in the treatment of patients with incipient senile atherosclerotic encephalopathy]. Man'kovskiĭ NB; Mints AIa; Karaban' IN; Litvinenko AA; Bachinskaia NIu Vrach Delo; 1987 Jan; (1):46-9. PubMed ID: 3564418 [No Abstract] [Full Text] [Related]
16. Use of Cavinton drip infusion in ophthalmology. II. Effect of Cavinton drip infusion in eye diseases caused by vascular occlusion or stenosis. Imre G Ther Hung; 1986; 34(2):84-6. PubMed ID: 3449973 [No Abstract] [Full Text] [Related]
17. [About cavinton therapy of the patients with brain vascular diseases]. Nikitina VV; Pravdina AN; Zapatrina OV Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611 [No Abstract] [Full Text] [Related]
18. Atypical posterior reversible encephalopathy syndrome in puerperium. Morelli N; Gori S; Michelassi MC; Falorni M; Cafforio G; Bianchi MC; Cosottini M; Orlandi G; Murri L; Tartaglione A Eur Neurol; 2008; 59(3-4):195-7. PubMed ID: 18230881 [No Abstract] [Full Text] [Related]
19. Therapeutic action of Cavinton in hearing defects of neurological origin. Ordögh B; Sárossy D; Klimstein G Ther Hung; 1978; 26(1):16-9. PubMed ID: 663871 [No Abstract] [Full Text] [Related]